INVO Fertility (IVF) Liabilities and Shareholders Equity (2010 - 2025)

INVO Fertility has disclosed Liabilities and Shareholders Equity across 16 years of filings, most recently posting $18.8 million for Q3 2025.

• Quarterly Liabilities and Shareholders Equity rose 42318.68% year-over-year to $18.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $116.3 million (up 181.36% YoY) and the FY2024 annual result came in at $46.4 million, up 151.0% from the prior year.
• Liabilities and Shareholders Equity slipped to $18.8 million in Q3 2025, from $19.3 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $46.4 million in Q4 2024 and bottomed at $44396.0 in Q3 2024.
• The 5-year median for Liabilities and Shareholders Equity is $10.0 million (2021), against an average of $12.9 million.
• Year-over-year, Liabilities and Shareholders Equity slumped 99.74% in 2024 and jumped 42318.68% in 2025.
• INVO Fertility's Liabilities and Shareholders Equity stood at $10.0 million in 2021, then sank by 62.88% to $3.7 million in 2022, then soared by 398.84% to $18.5 million in 2023, then surged by 151.0% to $46.4 million in 2024, then tumbled by 59.46% to $18.8 million in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $18.8 million, $19.3 million, and $31.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.